BSECompany Update2d ago · 5 Nov 2026, 01:55 pm
Please find enclosed the Earnings Presentation for the second quarter and half year ended September 30, 2026
Ion Exchange India Ltd-$ · 500214
✦ AI SummaryResults
Ion Exchange India Ltd has announced its Q2 FY 2026-27 earnings presentation, showing a decline in operating EBITDA margins and net profit margins for both standalone and consolidated financials.
Analysis Scores
Earnings Impact4/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Ion Exchange India Ltd-$ - 500214 - Earnings Presentation - Q2 FY 2026-27
Attachments (1)
📄pdf
Download →
65b62926-3313-4baa-8bd3-9525ca2f1b07.pdf
View document text
November 5, 2026
BSE Limited National Stock Exchange of India Limited
The Corporate Relationship Dept. Exchange Plaza, C-1, Block- G,
P.J. Towers, Dalal Street Bandra Kurla Complex, Bandra (East),
Mumbai-400 001 Mumbai-400 051
Scrip Code: 500214 Symbol: IONEXCHANG
Sub.: Submission of Earnings Presentation – Q2 FY 2026-27
Dear Sir/ Madam,
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the presentation
being made to the Investors and Analysts (Group Meet) to discuss the financial performance of the
Company for the second quarter and half year ended September 30, 2026.
The aforesaid information is also available on the website of the Company and can be accessed
at www.ionexchangeglobal.com.
Kindly take the information on record.
Thanking You,
Yours faithfully,
For Ion Exchange (India) Limited
Nikisha Solanki
Company Secretary & Compliance Officer
ACS- 50894
Encl.: As stated above
Earnings Presentation
Q2/H1-FY27
Company Snapshot
OPERATIONS IN
62 +
50 + °
TOTAL WATER &
YEARS OF
ENVIRONMENT MANAGEMENT
EXPERTISE COUNTRIES
SERVING
ONE OF ASIA’S EXPORTS INDUSTRIES,
WORLD CLASS
LARGEST SERVICE ACROSS INSTITUTIONS,
MANUFACTURING
NETWORKS CONTINENTS HOMES &
FACILITIES
COMMUNITIES
GLOBAL ASSEMBLY HUBS IN ADVANCED R&D COMMITTED TO
UAE, SAUDI ARABIA, SOUTH
CENTRES IN INDIA SUSTAINABILITY
AFRICA, INDONESIA &
BANGLADESH
200,000 + 3,000 +
INSTALLATIONS WORLD-WIDE CORE INDUSTRY PROJECTS
Total Water & Environment Management Solutions
Management of Specialty Resins / Adsorbents / Industrial Wastewater Treatment
Process Water Membranes / Chemicals / Enzymes for Recycle & Zero Liquid Discharge
Purification & Concentration
Drinking Water
Treatment
Process
Water
Treatment –
Sewage Treatment,
Ion Exchange
Tertiary Sewage
& Membrane
Recycle, Sludge
Based
Management
Pretreatment
Capabilities
Leaders in Resins, Membranes & Chemicals, with a Unique End-to-End Portfolio
Spanning Solutions, Digital & Services
RESINS MEMBRANES CHEMICALS SOLUTIONS SERVICES DIGITAL
1 2 3 4 5 6 7 8
SOURCE WATER & PROCESS WATER HIGH PURITY ULTRA PURE INDUSTRIAL WASTEWATER ZERO LIQUID MUNICIPAL & SEWAGE DRINKING
PRETREATMENT TREATMENT WATER WATER TREATMENT DISCHARGE TREATMENT WATER SOLUTIONS
Global Presence
COUNTRIES SERVED
INTERNATIONAL
REVENUE SHARE
GLOBAL MANUFACTURING
FACILITIES & ASSEMBLY CENTRES
200,000+
GLOBAL
INSTALLATIONS
Our Global Offices
Global Manufacturing Facilities
Ankleshwar, Gujarat Roha, Maharashtra Verna, Goa
Resins Manufacturing - Exports Non-Solvent Resins Centre of Membrane Excellence
Patancheru, Telangana Saudi Arabia Portugal
Chemicals Manufacturing Chemical Blending Facility MAPRIL, Manufacturing Facility
Global Manufacturing Facilities
Hosur, Tamil Nadu Verna, Goa Wada, Maharashtra Palaspe, Maharashtra
Standard Systems Assembly Standard Membrane Systems Standard Systems Assembly Large System Assembly
UAE South Africa Indonesia Bangladesh
Assembly Unit, ICV Certified Facility Manufacturing Facility Assembly and Testing Center Fabrication Unit & Assembly Centre
Current vs New Reporting Segments
Ion Exchange (India) Ltd.
Current Reporting
Engineering Chemicals Consumer Products
New Reporting
Institutional
Treatment Industrial Lifecycle Specialty Consumer
Solutions Products Services Chemicals Products
New Reporting Segments
TREATMENT INDUSTRIAL LIFECYCLE SPECIALTY CONSUMER
SOLUTIONS PRODUCTS SERVICES CHEMICALS PRODUCTS
1 2 3 4 5
▪ Water Treatment ▪ Standard Water ▪ Operations & ▪ Water Treatment ▪ Home Water Solutions
Treatment Solutions Maintenance (O&M) Chemicals
▪ Ultra Pure Water ▪ Community Water
▪ Membranes (RO, UF, ▪ Rehabilitation & ▪ Utility Chemicals Treatment Solutions
▪ High Purity Water
NF, MBR) Modification ▪ Process Chemicals
▪ Wellness
▪ Desalination
▪ Institutional Water ▪ Spares, Services & ▪ Membrane Chemicals
▪ Hydrogen Water
▪ Wastewater Treatment
Treatment Products Consumables ▪ Polymers
& Recycle ▪ Alkaline Water
▪ BOO/BOOT/WaaS ▪ Resins
▪ Zero Liquid Discharge
▪ Rentals ▪ Industrial
(ZLD)
▪ Audits ▪ Process
▪ PFAS
▪ Pharma
▪ Remote Monitoring
Financial Overview
Q2/H1-FY27
Q2-FY27 Financial Highlights
Q2-FY27 Performance (Standalone) Q2-FY27 Performance (Consolidated)
(12.57) %
(12.55) % INR (848) Mn
INR 6,157 Mn INR (773) Mn INR 6,747 Mn
Operating EBITDA
Operating EBITDA Operating EBITDA
Operating Income Operating EBITDA Operating Income
Margins
Margins
INR (5.804)/ INR (6.837)/
INR (714) Mn (11.60) % INR (828) Mn (12.27) %
Share Share
Net Profit PAT Margins Net Profit PAT Margins
Diluted EPS Diluted EPS
Order Book and Pipeline (As on 30 September, 2026) for Treatment Solutions, Industrial Products & Lifecycle Services
Engineering projects^ Outstanding Sri Lanka Outstanding UP SWSM Total Orderbook Bid Pipeline
~ INR 26,960 Mn ~ INR 100 Mn ~ INR 2,630 Mn ~ INR 29,690 Mn ~ INR 93,700 Mn
^Excluding Sri Lanka Order and UP SWSM.
H1-FY27 Financial Highlights
H1-FY27 Performance (Standalone) H1-FY27 Performance (Consolidated)
(3.73) % (3.85) %
INR (530) Mn
INR 12,513 Mn INR (467) Mn INR 13,752 Mn
Operating EBITDA Operating EBITDA
Operating EBITDA
Operating Income Operating EBITDA Operating Income
Margins Margins
INR (4.877) / INR (6.490) /
INR (600) Mn (4.80) % INR (797) Mn (5.80)%
Share Share
Net Profit PAT Margins Net Profit PAT Margins
Diluted EPS Diluted EPS
Quarterly/Half Yearly Segmental Breakup
Treatment Solutions
Standalone Consolidated
2,901
INR Mn
2,958
1,430
1,498
(122)
(1,139)
(1,215)
Q2-FY26 Revenue EBIT Q2-FY27 Q2-FY26 Revenue EBIT Q2-FY27
4,797
INR Mn 4,633 3,597
3,440
(1,389)
Revenue EBIT
(1,321) H1-FY26 H1-FY27
H1-FY26 H1-FY27
Revenue EBIT
Quarterly/Half Yearly Segmental Breakup
Industrial Products
Standalone Consolidated
1,360
INR Mn 1,342
1,009
74 86
102 111
Q2-FY26 Q2-FY27
Revenue EBIT
Q2-FY26 Q2-FY27
Revenue EBIT
INR Mn
2,397 2,411
1,858 1,931
148 210
H1-FY26 H1-FY27
H1-FY26 H1-FY27
Revenue EBIT
Revenue EBIT
Quarterly/Half Yearly Segmental Breakup
Lifecycle Services
Standalone Consolidated
INR Mn 659 611 770
Revenue EBIT Q2-FY26 Q2-FY27
Q2-FY26 Q2-FY27
Revenue EBIT
INR Mn
1,197 1,329 1,422
1,127
71 130
H1-FY26 H1-FY27
H1-FY26 H1-FY27
Revenue EBIT
Revenue EBIT
Quarterly/Half Yearly Segmental Breakup
Specialty Chemicals
Standalone Consolidated
2,546
INR Mn 2,138 2,181
1,827
537 629
233 225
Q2-FY26 Q2-FY27 Q2-FY26 Q2-FY27
Revenue EBIT Revenue EBIT
3,999
4,843
INR Mn 3,297
4,070
1,091
H1-FY26 H1-FY27 H1-FY26 H1-FY27
Revenue EBIT Revenue EBIT
Quarterly/Half Yearly Segmental Breakup
Consumer Products
Standalone Consolidated
INR Mn 1,005 1,005
(24) (43) (23) (41)
Q2-FY26 Q2-FY27
Q2-FY26 Q2-FY27
Revenue EBIT
Revenue EBIT
2,129 2,129
INR Mn
1,613 1,613
(29) (47) (27) (45)
H1-FY26 H1-FY27 H1-FY26 H1-FY27
Revenue EBIT Revenue EBIT
Q2/H1-FY27 Operational Highlights
Treatment Solutions:
▪ Change in the estimated cost to complete a few legacy projects in the Treatment Solutions segment has significantly impacted the Company financials for
this quarter.
▪ Turnover for Treatment solutions was impacted by the execution of certain high-value contracts being scheduled for H2. Dispatches to GCC markets were
delayed due to the ongoing Middle East crisis.
Industrial Products:
▪ Industrial Products delivered strong growth during the quarter, recording an increase of approximately 35% YoY.
Lifecycle Services:
▪ Lifecycle services recorded sequential growth during the quarter, while maintaining stable margins.
Specialty Chemicals:
▪ Specialty Chemicals recorded sequential and YoY improvement in turnover during the quarter.
▪ Margins remained under pressure due to input cost inflation arising from the West Asia crisis and costs associated with the Roha facility.
▪ Improved cost pass-through to customers is expected to support margin recovery in the coming months.
Consumer Products:
▪ Consumer Products segment continued to deliver strong volume growth during the quarter.
Other Updates:
▪ Our Advanced Digital solutions o
[Showing first 8,000 characters — download PDF for full document]